Eagle Meds Services
Stivarga (regorafenib)
Available to sourceHuman Prescription DrugOncology & Specialty

Stivarga (regorafenib)

40 mg/1 · Film-Coated Tablet
By Bayer HealthCare Pharmaceuticals Inc.
NDC
50419-171
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor , Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A9 Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTICNDC 50419-171-04Available to order
  • 3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)NDC 50419-171-03Available to order
  • 4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)NDC 50419-171-06Available to order
  • 210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLENDC 50419-171-00Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Stivarga (regorafenib)
NDC 50419-171